In the racemic title compound, C 20 H 16 N 2 O 5 , the pyran ring adopts a shallow envelope conformation, with the stereogenic C atom displaced from the other atoms by 0.273 (2) Å . The dihedral angle between the fused-ring system and the pendant p-tolyl group is 87.62 (7)
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Crystal data
uncontrolled growth of abnormal cells, is a major worldwide problem. It is a fatal disease standing next to the cardiovascular disease in terms of morbidity and mortality. Although the cancer research has led to a number of new and effective solutions, the medicines used as treatments have clear limitations and unfortunately cancer is projected as the primary cause of death in the future (Gibbs et al. 2000; Varmus et al. 2006 ).
The title compound, Fig. 1 , consists of a chromene moiety attached to a nitrophenyl ring, a nitro group and a methylamine group. The molecular structure is stabilized by an intra molecular N1-H1A···O5 interaction, which generates an S(6) ring motif. The chromen ring is almost coplanar with the least-square planes of the phenyl ring, making dihedral angle of 87.18 (8)°. The six-membered pyran ring(C7/O1/C8/C10/C11/C12) adopts sofa conformatons, with puckering parameters Q 2 = 0.1787 (17) Å, Q 3 = -0.0688 (18) Å and φ 2 = 0.9 (6)°, respectively. The C18 atom deviates from mean plane of the phenyl ring by -0.0260 Å. The title compound exihibits structural similarities with an already reported related structure (Narayanan et al. 2013 ).
In the crystal, the molecules are linked via intermolecular C9-H9C···O4 hydrogen-bond interaction to generate [010] chains.
S2. Experimental
A solution of 4-methylbenzaldehyde (1.0 mmol), 4-hydroxycoumarin (1.0 mmol), NMSM (1.0 mmol), and piperidine (0.2 equiv) in EtOH (2 ml) was stirred for the three hours. After reaction was complete as indicated by TLC, the product was filtered and washed with EtOH (2 ml) to remove the excess base and other impurities. Finally, the product was recrystallized from EtOH to yield colourless blocks of the title compound.
S3. Refinement
N and C-bound H atoms were positioned geometrically (C-H = 0.93-0.98 Å) and allowed to ride on their parent atoms, with U iso (H) = 1.5U eq (C) for methyl H atoms and 1.2U eq (C) for all other H atoms.
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Figure 1
The molecular structure of the title molecule, with atom displacement ellipsoids drawn at the 30% probability level. The intramolecular N-H···O hydrogen bond, which generates an S(6) ring motif, is shown as a dashed line.
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Figure 2
The crystal packing of the title compound, viewed along the b axis, showing C9-H9C···O4 hydrogen bonds producing chains parallel to the 101 planes.
2-Methylamino-3-nitro-4-p-tolylpyrano[3,2-c]chromen-5(4H)-one
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